These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 27166197)

  • 1. Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.
    López-Díez R; Shekhtman A; Ramasamy R; Schmidt AM
    Biochim Biophys Acta; 2016 Dec; 1862(12):2244-2252. PubMed ID: 27166197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline mitigates renal glycoxidative stress in obese mice by inhibiting AGE/RAGE signaling and increasing glyoxalase levels.
    Inacio MD; Costa MC; Lima TFO; Figueiredo ID; Motta BP; Spolidorio LC; Assis RP; Brunetti IL; Baviera AM
    Life Sci; 2020 Oct; 258():118196. PubMed ID: 32763295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Rabbani N; Thornalley PJ
    Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
    Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
    Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
    Shekhtman A; Ramasamy R; Schmidt AM
    Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation endproducts: from precursors to RAGE: round and round we go.
    Ramasamy R; Yan SF; Schmidt AM
    Amino Acids; 2012 Apr; 42(4):1151-61. PubMed ID: 20957395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis.
    Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T
    Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The receptor for advanced glycation end products (RAGE) and DIAPH1: unique mechanisms and healing the wounded vascular system.
    Ramasamy R; Friedman RA; Shekhtman A; Schmidt AM
    Expert Rev Proteomics; 2019 Jun; 16(6):471-474. PubMed ID: 30324836
    [No Abstract]   [Full Text] [Related]  

  • 10. RAGE and glyoxalase in kidney disease.
    Inagi R
    Glycoconj J; 2016 Aug; 33(4):619-26. PubMed ID: 27270765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.
    Pugazhenthi S; Qin L; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1037-1045. PubMed ID: 27156888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.
    Yamagishi SI
    Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.
    Blackburn NJR; Vulesevic B; McNeill B; Cimenci CE; Ahmadi A; Gonzalez-Gomez M; Ostojic A; Zhong Z; Brownlee M; Beisswenger PJ; Milne RW; Suuronen EJ
    Basic Res Cardiol; 2017 Sep; 112(5):57. PubMed ID: 28864889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the receptor for advanced glycation end products and consequences on health.
    Wautier MP; Guillausseau PJ; Wautier JL
    Diabetes Metab Syndr; 2017; 11(4):305-309. PubMed ID: 27612394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for the Advanced Glycation End Products (
    Gutowska K; Czajkowski K; Kuryłowicz A
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
    Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
    Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity.
    Gaens KH; Stehouwer CD; Schalkwijk CG
    Curr Opin Lipidol; 2013 Feb; 24(1):4-11. PubMed ID: 23298958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Glyoxalase System in Age-Related Diseases: Nutritional Intervention as Anti-Ageing Strategy.
    Aragonès G; Rowan S; Francisco SG; Whitcomb EA; Yang W; Perini-Villanueva G; Schalkwijk CG; Taylor A; Bejarano E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation.
    Yamagishi SI; Sotokawauchi A; Matsui T
    Mini Rev Med Chem; 2019; 19(13):1040-1048. PubMed ID: 30854960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis.
    Nienhuis HL; Westra J; Smit AJ; Limburg PC; Kallenberg CG; Bijl M
    Autoimmunity; 2009 May; 42(4):302-4. PubMed ID: 19811283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.